Elfrida R. Benjamin, Ph.D.
Senior Director, Translational Sciences, Amicus Therapeutics, Inc.
HINJ honored Dr. Benjamin for her highly respected translational science research in the development of pharmacological chaperones and enzyme replacement therapies for the treatment of lysosomal storage diseases such as Fabry and Pompe diseases. Dr. Benjamin’s innovative work is helping usher in a revolutionary chapter in drug development: precision medicine, an approach for drug development and disease treatment and prevention that factors in the individual patient’s genetic makeup.
